Psoriatic Arthritis Clinical Trials

Find clinical trials for psoriatic arthritis. Search for psoriatic arthritis clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 43

GuselkumabElucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

Recruiting

Sponsor:

UCLA

Location:

San Diego CA

Code:

NCT06586281

Conditions

Psoriatic Arthritis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Guselkumab

Tirzepatide & IxekizumabA Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Recruiting

Sponsor:

Eli Lilly and Company

Location:

Avondale AZ, Chandler AZ, Flagstaff AZ, Gilbert AZshow 48 more

Code:

NCT06864026

Conditions

Psoriatic Arthritis

Overweight or Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide

SonelokimabEvaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Recruiting

PHASE3

Sponsor:

MoonLake Immunotherapeutics AG

Location:

Chandler AZ, Flagstaff AZ, Mesa AZ, Phoenix AZshow 21 more

Code:

NCT06641076

Conditions

Arthritis, Psoriatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sonelokimab

Placebo

SonelokimabEvaluation of Sonelokimab in Patients with Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Recruiting

PHASE3

Sponsor:

MoonLake Immunotherapeutics AG

Location:

Scottsdale AZ, Upland CA, Middleburg Heights OH, Duncansville PAshow 5 more

Code:

NCT06641089

Conditions

Arthritis, Psoriatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sonelokimab

Placebo

Risankizumab

GuselkumabA Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

Recruiting

Sponsor:

Janssen Research & Development, LLC

Location:

Quebec, Avondale AZ, Chandler AZ, Mesa AZshow 38 more

Code:

NCT04929210

Conditions

Arthritis, Psoriatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Guselkumab

Placebo

JNJ-77242113A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

DeBary FL, Plantation FL, Willowbrook IL, Charlotte NCshow 1 more

Code:

NCT06878404

Conditions

Arthritis, Psoriatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Icotrokinra

Placebo

Active reference comparator

Cardiovascular PreventionPrevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

Recruiting

Sponsor:

University of Pennsylvania

Location:

Fort Smith AR, Columbus IN, Indianapolis IN, Northville MIshow 6 more

Code:

NCT05908240

Conditions

Psoriasis

Psoriatic Arthritis

Psoriatic Conditions

Cardiovascular Diseases

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Care Coordinator Model

Observational StudyRheumatology Diet Study

Recruiting

Sponsor:

University of Central Florida

Location:

Orlando FL

Code:

NCT06339957

Conditions

Diet Habit

Rheumatologic Disease

Autoimmune Diseases

Rheumatoid Arthritis

Psoriatic Arthritis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Ustekinumab & GuselkumabA Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Los Angeles CA, Boston MA, Bronx NY, New York NYshow 4 more

Code:

NCT05083182

Conditions

Arthritis, Juvenile

Eligibility Criteria

Sex: All

Age: 5 - 17

Healthy Volunteers: Not accepted

Interventions

Ustekinumab

Guselkumab

Immune Checkpoint InhibitorsTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Recruiting

Sponsor:

M.D. Anderson Cancer Center

Location:

Houston TX

Code:

NCT04751396

Conditions

Ankylosing Spondylitis

Autoimmune Disease

Crohn Disease

Enteropathic Arthritis

Enteropathic Spondylitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Best Practice

Educational Intervention

Interview

Questionnaire Administration

Survey Administration